Thursday, 11 April 2019

Lupin Has Announced That It Has Received Approval For Its Testosterone Gel

Lupin has announced that it has received approval for its Testosterone Gel, 1.62% , from the United States Food and Drug Administration.

Lupin's Testosterone Gel is the generic equivalent of AbbVie's AndroGel. 

It is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.


For more information +91- 6232578593 or visit www.moneymarketmanthan.com

No comments:

Post a Comment

Trends On SGX Nifty Indicate A Positive Opening For The Broader Index In India

Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 31.5 points gain or 0.25 percent. The Nifty future...